0001493152-24-022355.txt : 20240603 0001493152-24-022355.hdr.sgml : 20240603 20240603150034 ACCESSION NUMBER: 0001493152-24-022355 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240603 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novo Integrated Sciences, Inc. CENTRAL INDEX KEY: 0001138978 STANDARD INDUSTRIAL CLASSIFICATION: ENGINES & TURBINES [3510] ORGANIZATION NAME: 06 Technology IRS NUMBER: 593691650 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40089 FILM NUMBER: 241013225 BUSINESS ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 100 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: (206) 617-9797 MAIL ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 100 CITY: BELLEVUE STATE: WA ZIP: 98004 FORMER COMPANY: FORMER CONFORMED NAME: TURBINE TRUCK ENGINES INC DATE OF NAME CHANGE: 20010420 8-K 1 form8-k.htm
false 0001138978 0001138978 2024-06-03 2024-06-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest reported): June 3, 2024

 

Novo Integrated Sciences, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   001-40089   59-3691650
(State or other jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification Number)

 

11120 NE 2nd Street, Suite 200, Bellevue, WA 98004

(Address of principal executive offices)

 

(206) 617-9797

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CF$ 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on which Registered
Common Stock   NVOS   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

As previously reported, Novo Integrated Sciences, Inc. (the “Company”) entered into a securities purchase agreement, dated April 26, 2023, with RC Consulting Consortium Group LLC (“RC”) in favor of SCP Tourbillion Monaco or registered assigns (the “Holder”), pursuant to which the Company issued an unsecured 15-year promissory note to the Holder (the “Note”) with a maturity date of April 26, 2038, in the principal sum of $70,000,000, which amount represents the $57,000,000 purchase price plus a yield (non-compounding) of 1.52% (zero coupon) per annum from the issue date.

 

On June 3, 2024, the Company and RC entered into an amendment (the “Amendment”) to the Note. Pursuant to the terms of the Amendment, at any time after 12 months and no later than 60 months from the commencement of the term and prior to an event of default, if the Company’s listed common stock closes over $15 per share for a period of five consecutive trading days, the Company may (upon its sole discretion), prepay up to 50% of the outstanding RC Note in restricted shares of the Company’s common stock, as prescribed under Rule 144, at a value equal to 15% greater than the average closing price of the Company’s common stock over the five consecutive days above $15 per share. In the event the Company elects to prepay any outstanding amount in restricted stock, upon the removal of the restriction, RC (or its designates) will be limited to selling no more than one-sixth the amount of shares available from the lifting of the Rule 144 restriction over a single 30-day period.

 

Except as set forth in the Amendment, all other provisions and conditions of the Note remain in full force and effect, including the Company’s right, on 15 days’ prior written notice, to prepay the Note at any time prior to an event of default.

 

The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

Item 7.01. Regulation FD Disclosure.

 

On June 3, 2024, the Company issued a press release announcing entry into the Amendment. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

The information included in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Amendment, dated June 3, 2024, by RC Consulting Consortium Group LLC in favor of SCP Tourbillion Monaco and the registrant.
99.1   Press release issued by the registrant on June 3, 2024.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Novo Integrated Sciences, Inc.
     
Dated: June 3, 2024 By: /s/ Robert Mattacchione
    Robert Mattacchione
    Chief Executive Officer

 

 

 EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

AMENDMENT

 

This Amendment (the “Amendment”) to the Promissory Note, dated April 26, 2023 (the “RC Note”), between RC Consulting Consortium Group LLC (“RC”) in favor of SCP Tourbillion Monaco and Novo Integrated Sciences Inc. (the “Company”) is made this 3rd day of June, 2024.

 

WHEREAS, it is in the best interest of all parties to facilitate this Amendment in connection with the RC Note.

 

NOW, THEREFORE, in consideration of the premises and mutual covenants and agreements set forth herein and in reliance upon the representations and warranties contained herein, the parties hereto covenant and agree as follows:

 

1. Amendment to the RC Note.

 

  a. The RC Note is hereby amended to DELETE in its entirety, Article I, Section 3 and contemporaneously herby amend to INSERT the following Article I, Section 3:

 

ARTICLE I. RANKING AND CERTAIN COVENANTS

 

3. Prepayment. At any time prior to the date that an Event of Default occurs under this Note, the Borrower shall have the right, exercisable on fifteen (15) calendar days prior written notice to the Holder of the Note, to prepay the outstanding Principal Amount and interest then due under this Note in accordance with this Section. Any notice of prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be fifteen (15) calendar days from the date of the Optional Prepayment Notice (the “Optional Prepayment Date”). On the Optional Prepayment Date, the Borrower shall make payment of the amounts designated below to or upon the order of the Holder as specified by the Holder in writing to the Borrower. If the Borrower exercises its right to prepay the Note in accordance with this Section 3, the Borrower shall make payment to the Holder of an amount in cash equal to the sum of: (w) 100% multiplied by the Principal Amount then outstanding plus (x) accrued and unpaid interest on the Principal Amount to the Optional Prepayment Date.

 

If the Borrower delivers an Optional Prepayment Notice and fails to pay the applicable prepayment amount due to the Holder of the Note as provided in this Section, then the Borrower shall forever forfeit its right to prepay any part of the Note pursuant to this Section 3.

 

At any time after 12 months and no later than sixty (60) months from the commencement of the term and prior to an Event of default, if the Company’s publicly listed common stock close over $15 per share for a period of five (5) consecutive trading days, the Company may (upon its sole discretion), prepay up to 50% of the outstanding RC Note in restricted shares of the Company’s common stock, as prescribed under Rule 144, at a value equal to 15% greater than the average closing price of the Company’s common stock over the five (5) consecutive days above $15 per share.

 

In the event the Company elects to prepay any outstanding amount in restricted stock, upon the removal of the restriction RC (or its designates) will be limited to selling no more than one sixth the amount of shares available from the lifting of the Rule 144 restriction over a single 30-day period.

 

2. No other terms, rights or provisions of the RC Note and related Transaction Documents are or should be considered to have been modified by the terms of this Amendment and each party retains all other rights, obligations, privileges and duties contained in the Transaction Documents and any other documents mutually agreed upon thereafter.

 

Signature Page Follows

 

 
 

 

Agreed, Accepted, and duly Authorized to sign, on this 3rd day of June, 2024.

 

NOVO INTEGRATED SCIENCES, INC.    
       
By: /s/ Robert Mattacchione   6/3/2024
Name: Robert Mattacchione   Date
Title: CEO    

 

RC CONSULTING LLC    
       
By: /s/ Roland Coston   6/3/2024
Name: Roland Coston   Date
Title: Member, Authorized Signer    

 

End of Signature Page

 

 

 

 EX-99.1 3 ex99-1.htm

 

Exhibit 99.1

 

 

Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note

 

BELLEVUE, Wash., June 3, 2024 – Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today the Company and RC Consulting Consortium Group LLC, in favor of SCP Tourbillion Monaco (“RC”), have amended the prepayment terms and conditions of the previously disclosed $70,000,000 promissory note, dated April 26, 2023 (the “RC Note”) to provide that, at any time after 12 months and no later than 60 months from the commencement of the term of the RC Note and prior to an event of default, if the Company’s listed common stock closes over $15 per share for a period of five consecutive trading days, the Company may prepay up to 50% of the outstanding RC Note in restricted shares, at a value equal to 15% greater than the average closing price of the Company’s common stock.

 

In addition, in the event the Company elects to prepay any outstanding amount in restricted shares of the Company’s common stock, upon the removal of the restriction RC (or its designates) will be limited to selling no more than one-sixth of the amount of shares available from the lifting of the Rule 144 restriction over a single 30-day period.

 

Except as set forth in the Amendment, all other provisions and conditions of the Note remain in full force and effect, including the Company’s right, on 15 days’ prior written notice, to prepay the Note at any time prior to an event of default.

 

Robert Mattacchione, the Company’s CEO and Board Chairman, stated, “The opportunity to equitize up to 50% of the debt represented by the RC Note at a significant premium further reinforces the significance of this funding potential to the Company. It is clear that RC believes strongly in the Company’s growth objectives, as well as in the Company as a long-term investment opportunity. The exclusive nature of the conversion right held by the Company preserves the non-dilutive benefit of the RC Note present from the onset. This amendment leaves the Company in a strategically advantageous position, both short and long term, post closing of the RC Note transaction.”

 

About Novo Integrated Sciences, Inc.

 

Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation. Novo offers an essential and differentiated solution to deliver, or intend to deliver, these services and products through the integration of medical technology, advanced therapeutics, and rehabilitative science.

 

We believe that “decentralizing” healthcare, through the integration of medical technology and interconnectivity, is an essential solution to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered both now and in the future. Specific to non-critical care, ongoing advancements in both medical technology and inter-connectivity are allowing for a shift of the patient/practitioner relationship to the patient’s home and away from on-site visits to primary medical centers with mass-services. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes the degradation of non-critical health conditions to critical conditions as well as allowing for more cost-effective healthcare distribution.

 

 

 

 

The Company’s decentralized healthcare business model is centered on three primary pillars to best support the transformation of non-catastrophic healthcare delivery to patients and consumers:

 

  ● First Pillar: Service Networks. Deliver multidisciplinary primary care services through (i) an affiliate network of clinic facilities, (ii) small and micro footprint sized clinic facilities primarily located within the footprint of box-store commercial enterprises, (iii) clinic facilities operated through a franchise relationship with the Company, and (iv) corporate operated clinic facilities.

 

  ● Second Pillar: Technology. Develop, deploy, and integrate sophisticated interconnected technology, interfacing the patient to the healthcare practitioner thus expanding the reach and availability of the Company’s services, beyond the traditional clinic location, to geographic areas not readily providing advanced, peripheral based healthcare services, including the patient’s home.

 

  ● Third Pillar: Products. Develop and distribute effective, personalized health and wellness product solutions allowing for the customization of patient preventative care remedies and ultimately a healthier population. The Company’s science-first approach to product innovation further emphasizes our mandate to create and provide over-the-counter preventative and maintenance care solutions.

 

Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient-first platforms.

 

For more information concerning Novo Integrated Sciences, please visit www.novointegrated.com.

 

Twitter, LinkedIn, Facebook, Instagram, YouTube

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in Novo’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown uncertainties and other factors which are, in some cases, beyond Novo’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Novo’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Novo assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

 

Chris David, COO & President

Novo Integrated Sciences, Inc.

chris.david@novointegrated.com

(888) 512-1195

 

 

 

 GRAPHIC 4 ex99-1_001.jpg begin 644 ex99-1_001.jpg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nvos-20240603.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 nvos-20240603_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 nvos-20240603_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
Jun. 03, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 03, 2024
Entity File Number 001-40089
Entity Registrant Name Novo Integrated Sciences, Inc.
Entity Central Index Key 0001138978
Entity Tax Identification Number 59-3691650
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 11120 NE 2nd Street
Entity Address, Address Line Two Suite 200
Entity Address, City or Town Bellevue
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98004
City Area Code (206)
Local Phone Number 617-9797
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol NVOS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://novointegrated.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm nvos-20240603.xsd nvos-20240603_lab.xml nvos-20240603_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "NVOS", "nsuri": "http://novointegrated.com/20240603", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "nvos-20240603.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "nvos-20240603_lab.xml" ] }, "presentationLink": { "local": [ "nvos-20240603_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://novointegrated.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-06-03", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-06-03", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://novointegrated.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001493152-24-022355-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-022355-xbrl.zip M4$L#!!0 ( !!XPUC*) "MK0H )E* * 97@Q,"TQ+FAT;>U<[W/: M/!+^GIG\#[K,M9/,$,B/IG.74&8(N"UW%#+@]IU^%+8(NMJ6*\E)>?_ZVY5D M,(22-G42TJ8S%+!E:;7[[#Z[DD+]O?^AV]C>JK_WFFUX)_BO[G?\KM>HU^P[ MW*VYV_7S?OLS&?J?N]Z;G;%(]"DY/$@U\7G,%.FQ:S(0,4TJ]D*%#)GDXQUX M$!Z]^-GGSDA,Y25/3@DTW6G4W_9[?K&/_3&->30]O:T7TU;QOYD==*?Q,AFI M]*Q>PPYAEA=ER'=&-/NF]VG$+^&"Y)>34D6NGS>\;Q,^XGI[Z_"@>EBOG3?* MG<#34G# $LUD23+_RVFXWFDT/WB]-KS\>JW3^-.5_+],:3Z>NHL\"1EV>5 ] MX4G)V/8G7&UO-6.6A/#29%=/&'D9A5\S<3:[^E*:[WMH%J(%P3874L1<*2&G MI"5\C1P='Q0G>#EFF9=U8A(Z:O&4L(W&B)1&61YLGE M]A9^%E+S+";OI,A2TNVVR.ZLD_QYPA,RIE="$C$FP]8%\44F1SR*N$C(!Y'0 M0!":A##FE2 = .VE-!(. \Z2 /3428+J@H M$:8#;&]Q!28*&,0UF-Z:<0YUZ" 02<("C8BYYGIB.G0P?;;L@UBVU_\+ M+.JC?=_V!YZQL+.,XB$#ET7C@%G1-*ED$'-@"/3K.-,9C:#A%4MHHNU%>BD9 M0^LJHIB&$258=0+8@"[Q/KQ)%G$* 8!DJ; 0D@PZ5O"0&0S"(;:\IE)"MX@B MD$53GD#LL#U5K# .8W@-<);+,1>#4 4"1)&X5J=/#4Q^\[SKD9;7[0XOFJU. M[]V;G8,=\_VBV6[GWW]Z#M<\U!-L>O#BC(R$! /O!Z BFBH0*/^T8]+ANC_X M^0&N&!@EH%$.9"W2'9=,9WH\,[R70YBKX%83=HR?0'_&$E>3T&.[A M3Y@5SKD#9B+( *,IH>@V0!+@+VVOZ_D>L@T')@)/XL 1TPIIHODB1CHX@,T[ MC@UA(,6P.!5 .4QD*IIBIWF?V&.G-_0&OG%$RRDF549!5O5Y>F\.N@^0\.0Y>:JC0'?J?5];:W.E4R:/;^"V&"-'MM"!L#O]GI MD5;_D]=K]OSAVNKUII@_#N0?TL2F9YKS%Z:3/Y9WEAUSCB'F -%=0.9'I\AT M5:0UTL3L;4HT/ RY)H?2TG%?:,L'BO>)=X75 Z2D;3:F4+02$0295"0#<:4M M,FQ%C$^>"RG%-5Q7$RQ,)O2*V9P3UZD@\V7?F RXHB/P8/#<,1]K+(EW#T_V M" 1Z\'XJL>Q43J!KR;6&!HD KV>Y?.]%A&.[--F-+C!?AOF9:R+32D.D@; ! MI3M/ IY"\MR,188T;U-C5T-!\X2$&5N>$(8S&@1 :R9]=@43W'1AITJ:H#PG M&(B2SK1K(J3M;1<4Z,KM?HI/@11S,VQO]?A# 7% MD$I9P,<\J/$XP7M#2*E,N#"^Y)C(KKIDL#)<"<68T=[:B?]X/5)]1^5.3:IK9L9L@8AC7'8O\ E(+F/3RRS7 M*F97HW8H#RKF$Z M!+D2X&,A5P'4=P#;O4J.]BS%^9P ";C)%F/\K';$U4BE)0]0?B.?RMLOS[8X M.\@;*2:$#,;E(Q:Z3&V0@3"'KUY5,!.BY(I&X.J&HE"6PY,7Y%*RN;5,I % MT4MFU&781[KD[381C&IMR%JI09/7T!&T6M3_LUMO@%MW$FLY9GRM8&K"(HB_ M:BEJ%Z$[3X"*R#6@+"ZHQP+0E^,H;XEQ':"_"Q[(BUFDVMO>NN8V2XYXS+7- M\A6+(AP28DP,_&)!*Q)FPHS=JW'2P#C.>>@5<*$AOEGDB2#OQFZ<,+F3+$AE MX@3=WD(?@-O'!_NXTV>#Q$/D3,\KGD]^0?^H^C06,'O"RB; &:2A8&AL!<5YD$5:<T\Z\]F M[6.$)7 L0E,'6DE<:61$L8,N;-/BN(Q")8W)XQ1$P+TX9;9Y[1RL\!4B(!VX MM%MX2,/\BD?LTI7^8;:TD^=VCPL3L<(49H/[>!C]S"#A[+K==X2TPVSRA;.H M!]2*"=(][XW<]SIGR7SWN&NVG<;0,$PF(7V\P#SGK=V/M6>,GM:6["_+EW?T MC_U]\I:S*#PEJ),S:/TUP]P<.B7[^WGL:G<^Y2,NF>XUFLX%^_S:>40A*3RL MGH!4D!3S$ :<6M,NQZ8:/, M.&[NM/4:Z&*%6D;@\E_V1PRKWU,(3ZC+(NQ?6_%^1RT4,%0SCF5P\]M[T;TG M;[C-9&@%2KQF$+ 4V+;B& PHIYGIB9#0WB;(($7%K@7B^;3Z\.-%0X;U&KZO M/*I6]J'*[ZAC:BAX!;2D-ISR\7QZNM8>MZ6%CR-U3=7CS3 MB*"*TVVU] MO]@JXRCV0R'\\2-J&=73#TWZ<#_*_71QB#LN6 JKV"*,-8"D7_ M4C0/ #[2P "@ &5X.3DM,2YH=&WM7&USVS82_JX9_0>#T^.7^$_^);Y^$K_=?O3OZ45P, M?CP]_GIC9,IZ5VQM5K48Z$(Y\5;-Q+DI9)GX@41<**M'&YB(J6>_=MZ>**0= MZ[)7FVI7X/'%P-#4M2E6QW(UPJJ;>Z)65W5/YGI<[HI4E;6R&R_W7[][.VCO MWQO)0N?SW5^B@)]U^KWR!&.E5R\?E4-7[>T_>04)T;KX./OK6+1Z/*E_9PZ/ MKR9ZJ.MN9V>GO_5G,KKN[**X_X*M]T_>?",NS@^_WE!7.SN]K?]N;F[U?ZK& M&^+@=/#UQL9?(Y![K,Q_"(MOS=1T.R=8>6QEK3)QD6I5IEA&EIDX/Q2'IG1- M7NMRS#\:6^NF$-]8TU3BH%!XZ+,O-Y/-3?XGSJPIM,-3<_'6U.KO(KJ?&E?K MT?Q>J\^F5.)I(K8WMY^)1V6&T3U!0B!5 M$FLT*<%@VA>/WQY<'!W\9U>\_?[=Q1?B<3U1XE&>_=R8O4-35+*GAXG0I1C)*78P(W%Q>"8&IK%# MG>?:E.*-*65JQ..P^?EAW#H1$SE50I*Z@S':M[*JDG,,X"* 51;>7E)39KK& M6H[6#\]-M6E9=FENG%JUF&II,24L)A$9"^^@LCH7VR]8SD]7I 4VR;86 M+$9OQN! M%J8Z-45!9T?\14Z(R_AS(($7 Z$0)XC 4FK* L%3F1I)' 0$/FJ?TR/KB&@G MU22\%2P>2FX*RS[:>BPJ?;B*M@F9:(>EW;3*B8:2G1&3I5-K4 M]'-M94:'#K6 OK4V['8*:(H_+0$E )W/-S^/?)BF=C68H*F1)VB(5:ZV.B4" M>7_G12JF,F^44#\W,J>%MIY_+L96+25)2T)1K!PK9H:6A7A2Q2)9)X8V__U[ MZD6BF[R7S)V4W8[,O-&S=Z%39C-8<4\J5VGMO*FR*M)@6_MD =]6KU4^\0&Z M _?<5,;O;E5AH*EQ6ER//!QT_#%,28.43#G(!+KKOA S.$ Q5##*0M.^(-,I M^$30!5=1&%@@Z[1ZQ XY^HX&7VX] M>[9"&-N\%&0Q^/;I9H_\N[?W![/X")D[ODI5A9M .FA23?X;2A.L@U$CW2SP MJM [@S'K;S#'-^?ZBY1],U1;8A6ZQ!M,Q;*IOX34: 0#(P-,\X8-:HW%=#L< M#R;08_ANOBO"5^$2FUE=UZJDBQA..VF9ZX*"]M5ZX^83RXOO06L_0N;.S5!9 M:.T;6=';46/9 MB*S2)=N$XWG+1V$EO(D&QFO\A5-AQ;+6'LFT6.R+$UQ#N%UR)1G60!X@8*AR M#1V'.=?6P$G/HS5?E\S8FAE=$,.?8)" 9H2=G)CA.J'/U4DT(D6.]7J,+G6) MYVL/.I=2ZPL2H[J"93LLV.W@UFJLBF*#J\#E0:[#IWO$1.69&*Z&!RQ4.PV" M*4W9RW3NH>-0E6JDZ^O0-AS#\AHCM%D3+1".C"ZLVX&8XK)Q,S I24Y0A3&D MGT-8,IOBP( +$0I ]"[@!2C[!%[E/9;$O;Y;;DVTA?0(O$I%]PVF4S@@ M)H9"9)T*60$;R73":$36F 0BM'7DZ&0._T&>@_QKJ1SY(6N:,09%07D0RCGH M"DA>VGEX/@50[W94:MP<(3B'].0:=L22D4*1%&L),1K)8&&,LZ!CO. MA;N#)F2:ON !#EH,.5:*10RNM!PNUB:4TM%@O-O79&2LK!1I2NGNPI%43.=2YQMU,#M]YP3\@ MM(^0N1^@N@&*,#:)0"M3E!VWV/@]S"6)F#$9264L"5M4$ M!K^DFO8+Q@+%9K!08H8GCO<;-02%^MW.1:52PGI$"*^(4(:9\MP#6!CV*]Y* MB" &8[SF7?SWV@(01!/PC)DQ:YR4Z($<6"?85$:!+35Q(YWK1E4 B M'JBEJO2UK[_##E"!G5%KK4!=39!< /)SXV9N3<4BW<#+750];>3\H5@KU_]'KBM4:8L"O.@,GWL =54H31:\72OW[ M1R??1S*N,?."F!D:F\% XMBK7*:78JO_'+*"6] 9.!DGIV<'1T M\O:;KSQ*F42/% 3<6R M;"O""R;O;%6*K OMTO7*ZJVS>4*'X\_C3]/)AYOX YD;D+N_'ORWKF%<6"UO M,T3HSOBT,+C0.+_ OAM/<=;:*K7P[I6&VEMV>$,%F.L:S@7X(M2-*_3Z];GJ MY/SE.6]AYT5^T34%[H[=O^9X^L]UN?:(PJ N,T7;]S;[VWCTC]?*#_-4K]Z= M'QV?MYW6BF?Z($'\FLZHNSW;1O09-[Q9E%K+G]&CK0?7BKZB2DXYCH>TZ#&) MI\$CU[;X'0_FGSLOOMQ9GLSO1_3O2>5K#CW/V$9WZ2G"6YA?SXR]='UQY$UN M3?@9[+O;8=-:SSO M"JH@D$$7.K4&U)H:VP!I.?9 -^8%(L!YMY.;E -60H\13B_F8].AN>JYVL.H M KXBI8"7O18><8$&$'%S$U,I'^,OH_$1'%<*1*I6T3#MS6%P3![ZB/6QGF)= M8^'W2!*+]6YLU6]K"U_9U)#H+^T =AXW!HMU-YH2B:6GBTP2(()E\V M5;FI$N"(*C?!-F/R "Z, ?EZ"17:]KY K+]5G**OR*K#87)@$5B,-Q"+"M! M9SUIG%!75>@1\-5\2@5RH.PK[>0(YK>T"'0[T*_!84D(#: MQ=EU&8 '=_;@SA[K.SD$U?^+*0L0^Y'R46R2&V8D<^@9!3C*)6 MBPNQ-!"SGM=23ER-!=NFT.\7\5ET==0(26E03L&S9["*\G@A[4]H$4&=HEII MIA6B^E7B>FJO*"RLP(1'4LTH-=:UDNW,-]?G=5OSE" @DZ;*A&*"I MJ9VNI[*QHM[#14*?\M>K!<(*ED/)$O=))7CO"W.O#7P-I_&YJR>DO* (J;(E M^=S;FP6JG"HH"(48XLWI**+LU]Q0?8W_!G5,UL5@NLO.\+P[R MO,T5MXSSRT[ERO!($- REFOD(YERCP/E'%1HF* FJQ49AI>+;A%?'[ M1"A;0(AKO,*Y5]/#)$HE2W*L5N& 2WUIK46YH$0EM[XHY"6 M&@*IY9GX=Q/FG7)M.$-^KV$. K*&2P;:-W&7=YV!T_0,MJ869&I 4N*R-+,R ML.)_OL82O@G6%,]A-M&DK=0UI%>U/Z005[@F!;(F#[/X^+SH;N>"3"GC2XE@_VJ+7\>7J/PW[KIA>IN] MTS:7[BIVKMU)2\)G0*^.EK@A6]$/-?\A:B$I+]XS6^V$XR01*66\$8BEF1IR M)QF4@AI5TSNO S) &%(LOK$/64P4Y,#TI]4P=5^8.YQ8 E%'7[%SK/[RG7/AQ*ZC[O?5?F$_KC7?ZO>=$?_?H? M4$L#!!0 ( !!XPUBECA.[U18 +*O + 9F]R;3@M:RYH=&WM7?M; MVLK3_YV_8E_><[['/J]?)5E@:Y)-9V=G/SLS.;G;_.S9TWN;O2UFA3W,*;5:+3?&,FF_T/8X ML5PAGU=RE\='/77$#)KAIN-24V732CHWKY>WCT^G1?NVSF-%\9NPDV)NH6EX MJLTJ1 M7Z1[/B M;G+Y6=&<:U/3&0C;H"X,(;94SN0+F4(ETDC&86JL(?B<'8J;7[93S125L)V% MP8ESBH_[U)E*7&-SX@[[A =0HU *"]ILL+392@Z>A@4])S.DU)H6'E"G+PL& M#V*MPG>VT)F36%H^B157A6>Z]B29XN!AK()CNXM-PY>Q0B>?3WO34J:X$=QT MV="F+M.RJC!DV7PE7TSC#&-4JZ<(_MMUN:NS^F[._YW:-9A+"3:38=\]?O,^ MW130D.EFSB<6"%SU/[U/NVSLYN0TS$&MG-_D[O]D,F2?,UW;)CWF[I 3:K!M M,M;&.Z33DG]WX760:-Q!K^0,)+)W+%RL7V%G%XMR!H%M7RE6 #'[[\-4]FBA<]4;49LY5X4KBH-^& M([^[1S,XY*VSH*GB D'+VNX+;4(<=Z*S]^D!:-XV4?*62\ZY 25.V"WI"H.: MF_X7F]"_S0>HX!J_":MIW+%T.MDFIC 9/N/C;5169L,,D!^XIC$3IP-^@E(G MG@'MJ+ZJC]TN8D;#.1V@AF3RE0S,(<*U]^E]JKIY_ >?36 :^F)\.Z8(Z;K4 MA-U.E@X>NX -[],.-RR=(1X$W<1:]KMRA&<'/4$A.>S; ?.2 MT3GF Y0*2S+)FPQ4QC<_$6?OY3'?*<)S8:/H^S/BS&8>K.9YD_Y /-V MIY'?BG$26 MT:ZGL\P9'4H+(KJ6W7+-'6$C^;_3L0=]8A[M8.PJHKT $[N0/7T.YT-H-5\$ON/Q%E5 MRJA?OSCIG+=;J=YYX[S=V\WU?W_$7B:?O7;SHMLY[[1[J<9)B[0OFQ\:)P=M MTCP]/N[T>IW3DQ5DOA P_R]U1MP]P^CX9W;I^9E1_2AN0GW?-5'4)@],RS'8^:;LH5 M4$S%>"E1BD381"EO:.^(&!!WQ/"19W.70_/ML3JB)AAG#=7%QTJM6%I5 :VN MCJ/SGX+1ZS)+V"[9P,\XFHR"J\<;1-0DWG@;R&P'\=_G^9C=UN#U@TH.]+H9 *D,C..T$H^":%CQ*7K M'SV3D>(FP4[>&&;#2(8JO7(,AH;"O*H6 U7U@YE=-N0.[@^Y&$=>8BNH@Z.+ MLYOO]A?^8%M!418#J?&^T_43<2-2G>DF ^FI7 8S-TG'5+-O3#4WVF,070IE MACAD3V5%J$,]%>+/S]#*@Y#RK5&*C =!4V+)=RN[GGPF1N^MNL3:$MP9AF[;9H7WRVRH?: M0U=#W G'V+_++%OA=L,?5%H;WWH/W]&,W-YD2 MB%X9G2S'='*?ZPR&K\_L9 7DXUM5G._?&N/?6.2*B_HUZQ3IW<]*?K:^RQ[X:G$W-PJ QV9O&U "CMHEG@K&+B=?I!?MQ M/V8_-C3-9HX3_#J"&DJR[6AK[2]6OE:9J/3AMF-YT79,("!=5Q2ED$^=M$G! MU$C/M1ESEQB0FV2>OZU?\%=(YN^DZHYKEYU&I_KPG4BEW9C)/@\K VE=/G?S'TL-YVEK*TZS[='V/Z3J[\19R M7IQA*D% MGII)/)T)QZ7Z5VXMCSJQR]''\\,BSY_\AE]66\I1C()TO5;-YY?OL*QV-#N0 M"&ZQ638,+[>H3MB8J9[+;S#"#6LE<]Y,_'HU./N=U; 03%G$LH;-Z/))NGHT^( ]/& M&4QDS:""Z ,+[K9RC/HZ9,-AC!PPD]E@ MW75,J.OY*72-;"'[=A3O568G[.!5 2X'\R*4%LCY=T+$ ;GY;*',S27TA=$9->0QUSHZ+ M)1\DDH7:5-LJE79^9:2*E0]I%E/JD6 M>@727U#X[0LSM83.E=!J\WA,:S; ML'CKR>CCCK1QL]KZ>C"^7QSTCN@32TU9I&DEH&?&EB31"'A;Q!VE1#-*(0(] ML23^*?"4\EF_Y!I[7OS8K[$G@CV- 'O.;(86!F91RZ-9Z W8IX/!LGC5QY/+ MT=Z^7OIPJ3\%!L4RF);3MA)8!.QEU A_=[*'E)*6*6STW]T-F?RR:VQZ\;JP MQJ8(-BG)V-1Q'(_9OT2HH_$'8W#PA98_/(F55/X)0BU0^(9QJL@RI0WU%SCU MEX]30=D7F/FRCD/>R[J>NNR7EL<*1/U^L MSW->J?+DN?SG>-6BGP4^(&VJCDA3IXZS/FEQ!XVK/OWHV%0+/?;>Q.@+?<-Y MI&S4U1Z;TM/SA>=R8Q-GNLH#RM^..'S3G2X%*Y^5OFR+(5@8)TJA+Z$FV7+5 MN=,=_+!O5/[P V:%6)[C?+_I.IJK0;IQSQ7J];,9IF\YUWO9)3P!L/F8EJP3 MQP=GQ^W#[OE8W"_>$M.)6)YHK%.8P)]/>VLE>"XEB/Y,V@D(YFL(HLMO7#BA MQ\VSX^I^<[3U6Z>A&?24=!"Z4$W"D2A=B/V.1K\OR\!M4HN[5"?'U+[&'/&X M2JT=O=?,6L?4T/5GJ?Z$J)A\@@1$ M$00+LT6H0S0VX*9_586_Z9LO)URC-+L]J4@V4+A;.W+C-U].R<)<7G)AX247 MF/'DAR$*_4SACE*F)I3 MQ&7YQW["?ECK0%9J^G62L?G#^9=.LUCM?/[P)'LD":<)$HF[<_#Q3X_X"BOS MHX+N(+4<1C&#V<=D$L=DOI"H-P+$93I3\0(E4\BPG.83U)(C)AV\1>WYR77JOV*U(@4Z"\U'0_'SH?IXIXLQ M]KE8_.*XS0)>"=NT<8GCTH(UILYLT@WGL5D52C1TK$*O*GC)P(+H;$:O,WT& MZ X$6E+<46%5EMZ8_E:$%06.9\",N$VQMHSN>O2GXS(CI63S2I:T\6XV/-D@ M""5A]B)IH8_)Y5'2QM!F*E3DO;C%32)MXFZ3-(7I>+JT?/%/((Y[!@'7S+/(T5$3PPR2AFYS MVCTWR8#>X U4 ])KGI%SX=E]KNMH%A\+DZK"-[*G>^K4<4"Z3HRG#T('D W; MW$Q%;6Q_)P8+!YP3CKDJ&@9F/%.R"Q^4<@;O"$8S':]I$C"-P$%@V !6]3N( M]7D"CZ=<^$X!)M7*8*$4$X9FI*"(+ZAB%3T5V=SLE+<#\H%R?VWE-\'!E?\' M%%,#G0@<8YLY('M'UORKO!46G(T/-*?"3]US@(8)(C;9 *<74UW!%<9+&)[P)BA:\)"ZFWM-7QTUU/)@*J/=93#9U-EC*9?A>UC9[(V*#Z @\\& MNPE*:&Q 80V0_\_ GCR!+2.2*+)A@5*78#)K.K" 4$+L+3(7TI9S@KY@!OH)AHS>4*Y+_V&JX3H?R!4S( ;' M)@5C$Z7*ER'%\\I#J%K,9T!T@5*N,?J5L=8>J\R":0>0P%S$%]"5P"Z8 2>A MH&[^I9R1(\2(>3"!-.ZGG@8:(P$"5)KB?>=@3GE0%9J%Z8GEP4BIE KER@Y, MG.AE#TG0://A" IA1+(L9V?P) #:6__T(EI&,/DW([-P2D84[W^&SFNM?66L MG8]8"D,E0R'CVIX!_4\6%GRB"6@50^M@G,J7A<#P]YD?/F>NKY'<(;C4Q.[H MQQL!86&<8 A_^J;6T+B(3HN4*BS9KV\EXP:KZU)U!$W!9&&H;;C'.>)][@+I M627LDD_ORPR*0L_1SE93(U_82SR>, *R)2,@73;TP*#$-7._15I@;H&] A[> MGXIWK#'GJ;R9T(N7UJT#\UAG,E9AFF!R8106,26,AL50)$L:)$01WQN/-A!% ME!F4I&HU@!+9$A1H>K:-:!>\$ F5+;Q@) EM8ICF0\]JHLT*ZR*N?]ST\Q00 M77Q#RE_ I$X@"!$$H:B1%2Y$J#V;Z . :8:K(RR)&H;4M&!]#)SN =>9%CC< MTO.4JZCCNWK!9G%*J=XQJT?Z?M*[AWZBOGVT\#1H-KT%_I;#+'"\_C?H+UR! M=4[[7/>[DIV#W^CX]&P"0W; FN/ADAR1THS/Y1,"!(CS.;AH9^F-%T'^4Y0I MI#DUOV6^29@TL.6K@"15?=S=EY,<[_:9VMQ 1/"J(#5.C>2"!@1ER3F&Q"(\ MS5H(:>5.:CKZB8.,418MN/X=Z0JD&I[!QX@AL"=1+:9BOT0;' B$&QN<=["? MM)2O3IJ_[J'G*W0&7*.W2F>7&@7%#1E6E"]VBZR:?P*:WL2VP"ROJ_C(;X\. M3*":-('VIXDH\M)8?Y!Q60K R'DAMM#JWO#W!,J[H;U+A>/WYQE84?5Z M:.,F"6[1"WL;_4J7_;DKQ)[@+%0^N_7(>:0 .*%=+&_O%]E'?SL3>.Z/3G." M)_S$I]&>WO=MR="^Y;^Q)\[8R[E'X3%YQIC.8VC::SB*\Q0J0\G(QA1L-E;R M&24[BVOQ&%$[!ERFL]>VAMPKC?JND3N8]8F*5356Y9]VB M+B7X?BBRP8P^TS"V@MD_P0Y>Q\1KMLGE7O>(:,$KQ2.'IU[,H;]5IT^_8*/6[P5M'J&ET'T.@&&JFR.>NY(V$#\2TA"6Z&8Y M_>\'S1N6 >?SV?;IP;[D^,J%XR")X M]>Z2@Q8O-P(W5;&R/(#Z(IVZ\-*[ETY@:>N)*?Q#%X0MN^CP\5AMX9S9EA1& M8S*/,SJ)\^7Q:-^;;#_7KL$3<[++ZSDG)QGHBC[TA4<%7:JJ(RY,?%?J"\6P MEPD+JT^5KR22DKBBK)5D3=4T9#KB;" ):4]?7'LJ7UQKO[SHY_-D%_TT(%G< M(:=RU];9)D?X L)U?/+UA]QPV*-$]!B4PAL#M\E8&^^03DO^<96O[EW)"X?\ M8SU(I:S&/H[WOUVT#V^_-3YU+W*?3F_'7WMYY9NF'>C=BW^=SO5EN]]O?ML[ M<8\-M?>]FSO\=SSZ.C[8XP>Y6B[W2?QH/%U MJVNT.DKMYGC(B^-#=VS:ETINX+346W&\9WRAA\6+TT]&SOUV?/R]\>.Z/ZGJ M7ZQ>\_RHK8QNQI?=S]7N(-E9L2;0^+E9[%^I\_ MCPM=LW?0_]0].OIT66E="Z/YX?*R\NER_.-BKU?F[7ZM>W"TKQW\7XOF/N3I M4?7ZZ,!R/EGY?N6L=O#A]JO1$[?O?8GD^D*;U $J1JZAU_\?4$L#!!0 ( M !!XPUB)T=V;+0, /4+ 1 ;G9O],_T'UN[&!A 8"R;1ADF$*21H:DNE+1]B+T2 D5Y*Y].LK^<;%A )M_22O MSCF[J]V5W;Q>3"F:@9"$LY95+KD6 N9QG["@93WW[4_]FT['0M=7[]\A_30_ MV#:Z)4#]!FISS^ZP$;]$]W@*#70'# 167%RB ::1L?!;0D&@&SX-*2C0&XFG M!CHO52H>LNT#= ? ?"Z>GSJY[EBI4#8<9SZ?EQB?X3D7$UGR^/0PP;["*I*Y MFKMPT^

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end XML 19 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001138978 2024-06-03 2024-06-03 iso4217:USD shares iso4217:USD shares false 0001138978 8-K 2024-06-03 Novo Integrated Sciences, Inc. NV 001-40089 59-3691650 11120 NE 2nd Street Suite 200 Bellevue WA 98004 (206) 617-9797 false false false false Common Stock NVOS NASDAQ false